Follicles on a letrozole cycle grow at roughly the same rate as in a natural cycle: about 1 to 2 mm per day, depending on their size. Smaller follicles grow more slowly, and the pace picks up as they get larger. Most people taking letrozole can expect a dominant follicle to reach trigger-ready size (around 18 to 21 mm) between cycle days 12 and 16, though individual timing varies.
Follicle Growth Rate by Size
Follicle growth isn’t constant. It accelerates as follicles mature, and the numbers break down into distinct phases. Very small follicles (2 to 5 mm) grow at roughly 0.6 mm per day. Once they reach 5 to 10 mm, that rate increases to about 1 mm per day. Between 10 and 16 mm, growth speeds up again to around 1.2 mm per day. Once a follicle crosses 14 mm and becomes pre-ovulatory, it can grow 1.5 to 2 mm per day until ovulation.
These rates come from natural cycle data, and letrozole cycles follow a similar pattern. Letrozole doesn’t directly speed up follicle growth. Instead, it creates the hormonal conditions that allow one or two follicles to develop fully, which is why the growth trajectory looks comparable to what your body would do on its own in an ovulatory cycle.
How Letrozole Stimulates Follicle Development
Letrozole works by temporarily blocking the enzyme that converts androgens into estrogen. When estrogen levels drop, your brain responds by releasing more follicle-stimulating hormone (FSH). That extra FSH is what drives follicle recruitment and growth. The effect is short-lived because letrozole is cleared from the body within a few days, which is why it tends to produce one or two dominant follicles rather than many. Your body’s own feedback system kicks back in quickly, allowing the strongest follicle to take over while the others fall behind.
This is a meaningful distinction from injectable fertility medications, which supply FSH directly and continuously, often producing multiple large follicles at once.
Typical Timeline During a Letrozole Cycle
Letrozole is usually taken for five days early in your cycle, most commonly on cycle days 3 through 7 or days 5 through 9. After you finish the medication, follicles continue developing on their own. The first monitoring ultrasound is typically scheduled around cycle day 10 to 12, when your clinic checks how many follicles are growing and how large they are.
At that first scan, a developing follicle might measure anywhere from 10 to 15 mm. If it’s around 12 mm on day 10, you can estimate it will take roughly another 4 to 6 days to reach 18 to 20 mm, based on the 1.2 to 2 mm per day growth rate at that size. Follow-up ultrasounds are scheduled every two to three days from that point, and daily as you approach ovulation. If a trigger shot is part of your protocol, it’s typically given when the lead follicle reaches the target size range.
Optimal Follicle Size for Ovulation
In letrozole cycles with a trigger shot, the best pregnancy outcomes occur when the dominant follicle measures between 19.1 and 21.0 mm on the day of the trigger. A large study on letrozole cycles with intrauterine insemination found an inverted U-shaped relationship between follicle size and pregnancy rates: follicles that were too small or too large at trigger time both led to lower success rates. The sweet spot was clearly in that 19 to 21 mm window.
If you’re not using a trigger shot and are timing intercourse based on natural ovulation signs, the dominant follicle will typically rupture on its own somewhere between 18 and 24 mm. Your clinic may still monitor follicle size to help you time things accurately.
What Happens When Growth Is Slow
Sometimes follicles don’t grow as expected. If your monitoring ultrasound on day 12 shows no follicle larger than 10 mm, that’s a sign the current dose may not be producing enough stimulation. One factor that can slow growth is elevated androgen levels within the follicle itself, which can reduce the rate of cell division in the follicle wall, particularly around the 15 mm stage.
If your follicles aren’t responding to the standard 2.5 mg dose of letrozole, your provider may increase the dose to 5 mg or 7.5 mg in a future cycle. The higher dose produces a more pronounced hormonal effect, more deeply suppressing estrogen and increasing other reproductive hormones that support follicle development. In clinical data comparing 2.5 mg and 5 mg doses, the higher dose lowered estrogen levels more significantly from day 5 of stimulation onward, though the number of mature follicles produced was similar between the two groups. The practical difference is that a higher dose may be what it takes to get a follicle growing in the first place for some people.
How Letrozole Compares to Clomiphene
Follicle growth rates on letrozole and clomiphene citrate are broadly similar. In a randomized trial comparing the two, letrozole produced an average of 2.1 follicles at 14 mm or larger, while clomiphene produced 1.7. The number of fully mature follicles (over 18 mm) was 1.4 with letrozole and 1.1 with clomiphene. These differences were not statistically significant, meaning neither drug consistently produces faster or more abundant follicle growth than the other.
Where the two medications differ more clearly is their effect on the uterine lining. Clomiphene can thin the endometrium in 15% to 50% of patients because it blocks estrogen receptors throughout the body, including in the uterus. Letrozole works differently: it lowers estrogen production temporarily rather than blocking the receptors, so the lining generally recovers once the drug clears. In one large study, average endometrial thickness was 8.5 mm with letrozole and 8.0 mm with clomiphene. That difference is small but was statistically significant. Among cycles that actually resulted in live births, however, lining thickness between the two drugs was nearly identical.
Success Rates With Letrozole
For context on what all this follicle growth is building toward, a large retrospective study of over 14,500 IUI cycles found that letrozole with IUI produced a live birth rate of 9.4% per cycle. That was significantly higher than natural-cycle IUI (6.2%) and comparable to clomiphene with IUI (8.9%) and injectable hormones with IUI (9.5%). These are per-cycle numbers, so cumulative rates over several cycles are considerably higher. Most clinics recommend trying three to six letrozole cycles before considering other approaches.